Frontlight ResearchEarly access
Trial site
Poznan
- 4running trials
- 5closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis3 trials
- Chronic spontaneous urticaria1 trial
- Coronary artery disease1 trial
- Gastric and oesophageal cancer1 trial
- High blood pressure1 trial
- Lupus (SLE)1 trial
- Pulmonary arterial hypertension1 trial
- Stroke1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 37 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Completed4 trials
- Active, not recruiting3 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals9 trials
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Active, not recruiting
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Completed
Terminated
Completed
Completed
Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026